Go to
JCI Insight
Citations to this article
Daisuke Tokuhara, … , Lennart Hammarström, Yoshikazu Yuki
Published August 8, 2013
Citation Information: J Clin Invest. 2013;123(9):3829-3838. https://doi.org/10.1172/JCI70266.
Citation Information: J Clin Invest. 2013;123(9):3829-3838. https://doi.org/10.1172/JCI70266.
Abstract
Rotavirus-induced diarrhea is a life-threatening disease in immunocompromised individuals and in children in developing countries. We have developed a system for prophylaxis and therapy against rotavirus disease using transgenic rice expressing the neutralizing variable domain of a rotavirus-specific llama heavy-chain antibody fragment (MucoRice-ARP1). MucoRice-ARP1 was produced at high levels in rice seeds using an overexpression system and RNAi technology to suppress the production of major rice endogenous storage proteins. Orally administered MucoRice-ARP1 markedly decreased the viral load in immunocompetent and immunodeficient mice. The antibody retained in vitro neutralizing activity after long-term storage (>1 yr) and boiling and conferred protection in mice even after heat treatment at 94°C for 30 minutes. High-yield, water-soluble, and purification-free MucoRice-ARP1 thus forms the basis for orally administered prophylaxis and therapy against rotavirus infections.
Authors
Daisuke Tokuhara, Beatriz Álvarez, Mio Mejima, Tomoko Hiroiwa, Yuko Takahashi, Shiho Kurokawa, Masaharu Kuroda, Masaaki Oyama, Hiroko Kozuka-Hata, Tomonori Nochi, Hiroshi Sagara, Farah Aladin, Harold Marcotte, Leon G.J. Frenken, Miren Iturriza-Gómara, Hiroshi Kiyono, Lennart Hammarström, Yoshikazu Yuki
Total citations by year
Citation information
Citations to this article (38)
| Title and authors | Publication | Year |
|---|---|---|
|
Screening and identification of nanobody against inhibin α-subunit from a Camelus bactrianus phage display library
Ma J, Bodai B, Ma Z, Khalembek K, Xie J, Kadyken R, Baibatshanov M, Kazkhan O |
Heliyon | 2024 |
|
A Nanobody of PEDV S1 Protein: Screening and Expression in Escherichia coli
Hao Z, Dong X, Zhang Z, Qin Z |
Biomolecules | 2024 |
|
Biotechnological Interventions for the Production of Subunit Vaccines Against Group A Rotavirus
Prajapati M, Malik P, Sinha A, Yadav H, Jaiwal YK, Ahlawat YK, Chaudhary D, Jaiwal R, Sharma N, Jaiwal PK, Chattu VK |
Cell Biochemistry and Function | 2024 |
|
Development of spirulina for the manufacture and oral delivery of protein therapeutics
B Jester, H Zhao, M Gewe, T Adame, L Perruzza, D Bolick, J Agosti, N Khuong, R Kuestner, C Gamble, K Cruickshank, J Ferrara, R Lim, T Paddock, C Brady, S Ertel, M Zhang, A Pollock, J Lee, J Xiong, M Tasch, T Saveria, D Doughty, J Marshall, D Carrieri, L Goetsch, J Dang, N Sanjaya, D Fletcher, A Martinez, B Kaldis, K Sigmar, E Afreen, T Nguyen, A Randolph, A Taber, A Krzeszowski, B Robinett, D Volkin, F Grassi, R Guerrant, R Takeuchi, B Finrow, C Behnke, J Roberts |
Nature Biotechnology | 2022 |
|
Research progress and applications of nanobody in human infectious diseases
Mei Y, Chen Y, Sivaccumar JP, An Z, Xia N, Luo W |
Frontiers in pharmacology | 2022 |
|
Lactobacilli as a Vector for Delivery of Nanobodies against Norovirus Infection
Yuki Y, Zuo F, Kurokawa S, Uchida Y, Sato S, Sakon N, Hammarström L, Kiyono H, Marcotte H |
Pharmaceutics | 2022 |
|
Development of Antibody-Fragment–Producing Rice for Neutralization of Human Norovirus
A Sasou, Y Yuki, S Kurokawa, S Sato, Y Goda, M Uchida, N Matsumoto, H Sagara, Y Watanabe, M Kuroda, N Sakon, K Sugiura, R Nakahashi-Ouchida, H Ushijima, K Fujihashi, H Kiyono |
Frontiers in Plant Science | 2021 |
|
Anti-CfaE nanobodies provide broad cross-protection against major pathogenic enterotoxigenic Escherichia coli strains, with implications for vaccine design
A Amcheslavsky, AL Wallace, M Ejemel, Q Li, CT McMahon, M Stoppato, S Giuntini, ZA Schiller, JR Pondish, JR Toomey, RM Schneider, J Meisinger, R Heukers, AC Kruse, EM Barry, BG Pierce, MS Klempner, LA Cavacini, Y Wang |
Scientific Reports | 2021 |
|
Therapeutic Applications of Functional Nanomaterials for Prostatitis
CP Liu, ZD Chen, ZY Ye, DY He, Y Dang, ZW Li, L Wang, M Ren, ZJ Fan, HX Liu |
Frontiers in pharmacology | 2021 |
|
Unprecedented enhancement of recombinant protein production in sugarcane culms using a combinatorial promoter stacking system
MB Damaj, JL Jifon, SL Woodard, C Vargas-Bautista, GO Barros, J Molina, SG White, BB Damaj, ZL Nikolov, KK Mandadi |
Scientific Reports | 2020 |
|
Inhibition of invasive salmonella by orally administered IgA and IgG monoclonal antibodies
AF Richards, JE Doering, SA Lozito, JJ Varrone, GG Willsey, M Pauly, K Whaley, L Zeitlin, NJ Mantis, TJ Bourret |
PLoS neglected tropical diseases | 2020 |
|
The Antigenic Topology of Norovirus as Defined by B and T Cell Epitope Mapping: Implications for Universal Vaccines and Therapeutics
JM van Loben Sels, KY Green |
Viruses | 2019 |
|
Development of Systems for the Production of Plant-Derived Biopharmaceuticals
KB Moon, JS Park, YI Park, IJ Song, HJ Lee, HS Cho, JH Jeon, HS Kim |
Plants | 2019 |
|
A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa
D Ruano-Gallego, DA Yara, LD Ianni, G Frankel, S Schüller, LÁ Fernández, BK Coombes |
PLoS pathogens | 2019 |
|
Lactic Acid Bacteria as a Live Delivery System for the in situ Production of Nanobodies in the Human Gastrointestinal Tract
del Rio B, Redruello B, Fernandez M, Martin MC, Ladero V, Alvarez MA |
Frontiers in microbiology | 2019 |
|
Viral gastroenteritis
K Bányai, MK Estes, V Martella, UD Parashar |
Lancet | 2018 |
|
Therapeutics and Immunoprophylaxis Against Noroviruses and Rotaviruses: The Past, Present, and Future
S Ghosh, YS Malik, N Kobayashi |
Current drug metabolism | 2018 |
|
Oral Administration of a Seed-based Bivalent Rotavirus Vaccine Containing VP6 and NSP4 Induces Specific Immune Responses in Mice
H Feng, X Li, W Song, M Duan, H Chen, T Wang, J Dong |
Frontiers in Plant Science | 2017 |
|
Single-Domain Antibodies As Therapeutics against Human Viral Diseases
Y Wu, S Jiang, T Ying |
Frontiers in immunology | 2017 |
|
Passive Immunization
Slifka MK, Amanna IJ |
Plotkin's Vaccines | 2017 |
|
Edible plants for oral delivery of biopharmaceuticals: Plant-made biopharmaceuticals
M Merlin, M Pezzotti, L Avesani |
British Journal of Clinical Pharmacology | 2016 |
|
Fusion of the mouse IgG1 Fc domain to the VHH fragment (ARP1) enhances protection in a mouse model of rotavirus
G Günaydın, S Yu, T Gräslund, L Hammarström, H Marcotte |
Scientific Reports | 2016 |
|
Biomanufacturing of protective antibodies and other therapeutics in edible plant tissues for oral applications
P Juarez, V Virdi, A Depicker, D Orzaez |
Plant Biotechnology Journal | 2016 |
|
Plant-based oral vaccines against zoonotic and non-zoonotic diseases
N Shahid, H Daniell |
Plant Biotechnology Journal | 2016 |
|
Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease
L Maffey, CG Vega, S Miño, L Garaicoechea, V Parreño, PL Ho |
PloS one | 2016 |
|
Potent In Vitro and In Vivo Activity of Plantibody Specific for Porphyromonas gingivalis FimA
YS Choi, JH Moon, TG Kim, JY Lee, DL Burns |
Clinical and vaccine immunology : CVI | 2016 |
|
The increasing value of plant-made proteins
M Sack, A Hofbauer, R Fischer, E Stoger |
Current Opinion in Biotechnology | 2015 |
|
Camelid nanobodies with high affinity for broad bean mottle virus: a possible promising tool to immunomodulate plant resistance against viruses
A Ghannam, S Kumari, S Muyldermans, AQ Abbady |
Plant Molecular Biology | 2015 |
|
Llama Nanoantibodies with Therapeutic Potential against Human Norovirus Diarrhea
L Garaicoechea, A Aguilar, GI Parra, M Bok, SV Sosnovtsev, G Canziani, KY Green, K Bok, V Parreño, K Sestak |
PloS one | 2015 |
|
Recombinant antibody production evolves into multiple options aimed at yielding reagents suitable for application-specific needs
A Marco |
Microbial cell factories | 2015 |
|
The mucosal immune system: From dentistry to vaccine development
H KIYONO, T AZEGAMI |
Proceedings of the Japan Academy, Series B | 2015 |
|
Passive Immunization: Toward Magic Bullets
Marcotte H, Hammarström L |
Mucosal Immunology | 2015 |
|
Vaccines against human diarrheal pathogens: Current status and perspectives
N Böhles, N Böhles, K Busch, K Busch, M Hensel, M Hensel |
Human Vaccines & Immunotherapeutics | 2014 |
|
Recent developments in therapeutic protein expression technologies in plants
Shah Fahad, Faheem Ahmed Khan, Nuruliarizki Shinta Pandupuspitasari, Muhammad Mahmood Ahmed, Yu Cai Liao, Muhammad Tahir Waheed, Muhammad Sameeullah, Darkhshan, Saddam Hussain, Shah Saud, Shah Hassan, Amanullah Jan, Mohammad Tariq Jan, Chao Wu, Ma Xiao Chun, Jianliang Huang |
2014 | |
|
Co-Expression of Anti-Rotavirus Proteins (Llama VHH Antibody Fragments) in Lactobacillus: Development and Functionality of Vectors Containing Two Expression Cassettes in Tandem
G Günaydın, B Álvarez, Y Lin, L Hammarström, H Marcotte, PN Boyaka |
PloS one | 2014 |
|
RNAi-mediated suppression of endogenous storage proteins leads to a change in localization of overexpressed cholera toxin B-subunit and the allergen protein RAG2 in rice seeds
S Kurokawa, M Kuroda, M Mejima, R Nakamura, Y Takahashi, H Sagara, N Takeyama, S Satoh, H Kiyono, R Teshima, T Masumura, Y Yuki |
Plant Cell Reports | 2013 |
|
Rice-derived rotavirus antibody shows promise
MT Tse |
Nature Reviews Drug Discovery | 2013 |
|
Rice yields new oral therapy for rotavirus infection
K Smith |
Nature Reviews Gastroenterology & Hepatology | 2013 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)